Gilder Gagnon Howe & CO LLC Bridge Bio Pharma, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

$7.59 Billion
Q2 2024

A detailed history of Gilder Gagnon Howe & CO LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 44,302 shares of BBIO stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,302

Previous 45,299 2.2%

Holding current value

$1.13 Million

Previous $1.4 Million 19.86%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $22,931 - $30,946	-997 Reduced 2.2%	44,302 $1.12 Million
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $141,590 - $209,409	5,177 Added 12.9%	45,299 $1.4 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $96 - $175	-4 Reduced 0.01%	40,122 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $77,187 - $159,995	4,570 Added 12.85%	40,126 $1.06 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $49,385 - $66,925	3,716 Added 11.67%	35,556 $611,000
Q1 2023 May 15, 2023	SELL	$7.17 - $18.55 $5,011 - $12,966	-699 Reduced 2.15%	31,840 $527,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $106,903 - $182,718	-15,861 Reduced 32.77%	32,539 $247,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $2,763 - $4,301	-348 Reduced 0.71%	48,400 $481,000
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $4.15 Million - $9.67 Million	-796,327 Reduced 94.23%	48,748 $443,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $1,357 - $3,174	-185 Reduced 0.02%	845,075 $8.58 Million
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $1.02 Million - $4.8 Million	89,938 Added 11.91%	845,260 $14.1 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $124,252 - $170,300	-2,651 Reduced 0.35%	755,322 $35.4 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $315,717 - $434,340	-6,794 Reduced 0.89%	757,973 $46.2 Million
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $42.4 Million - $55.3 Million	764,767 New	764,767 $47.1 Million

Others Institutions Holding BBIO

# of Institutions

292

Shares Held

175M

Call Options Held

8.66M

Put Options Held

2.76M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.77B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account

Gilder Gagnon Howe & CO LLC Bridge Bio Pharma, Inc. Transaction History